ロード中...
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease
BACKGROUND: It is suggested that neuroinflammation, in which activated microglial cells play a relevant role, contributes to the development of Parkinson’s disease (PD). Consequently, the modulation of microglial activation is a potential therapeutic target to be taken into account to act against th...
保存先:
| 出版年: | J Neuroinflammation |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8025338/ https://ncbi.nlm.nih.gov/pubmed/33823877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-021-02132-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|